Proterra Inc. (PTRA) Tops Q2 EPS by 40c

Proterra Inc. (NASDAQ: PTRA) reported Q2 EPS of $0.14, $0.40 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $85.71 million versus the consensus estimate of $92.63 million.

For earnings history and earnings-related data on Proterra Inc. (PTRA) click here.

You May Also Be Interested In

• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c